Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction
Clinical trial NCT07146360 · COMPLETED
Trial details
- NCT number
- NCT07146360
- Sponsor
- AO GENERIUM
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-25
- Primary completion
- 2017-11-21
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.